Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products? Technical brief | 11 November 2022 Transparency Research and development MSF Clinical Trial Transparency Policy Issue brief Issue brief | 08 November 2022 Tuberculosis DR-TB Drugs Under the Microscope, 8th Edition Prem Hessenkamp Press release Press release | 08 November 2022 Tuberculosis New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk 6 min Video Video | 03 November 2022 Tuberculosis MSF commitment to supporting the objectives of the ‘1/4/6 by 24’ campaign 2 min Technical brief | 02 November 2022 Intellectual property and trade Damaging provisions for access to medicines in the UK-India FTA negotiation text Photograph by Atul Loke Press release Press release | 02 November 2022 Intellectual property and trade United KingdomIndia MSF responds to UK's disastrous proposal on intellectual property in UK-India Free Trade Agreement 3 min Load More
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min
Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products?
Technical brief | 11 November 2022 Transparency Research and development MSF Clinical Trial Transparency Policy
Issue brief Issue brief | 08 November 2022 Tuberculosis DR-TB Drugs Under the Microscope, 8th Edition
Prem Hessenkamp Press release Press release | 08 November 2022 Tuberculosis New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk 6 min
Video Video | 03 November 2022 Tuberculosis MSF commitment to supporting the objectives of the ‘1/4/6 by 24’ campaign 2 min
Technical brief | 02 November 2022 Intellectual property and trade Damaging provisions for access to medicines in the UK-India FTA negotiation text
Photograph by Atul Loke Press release Press release | 02 November 2022 Intellectual property and trade United KingdomIndia MSF responds to UK's disastrous proposal on intellectual property in UK-India Free Trade Agreement 3 min
